These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32034019)

  • 1. Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial.
    Devanand DP; Andrews H; Kreisl WC; Razlighi Q; Gershon A; Stern Y; Mintz A; Wisniewski T; Acosta E; Pollina J; Katsikoumbas M; Bell KL; Pelton GH; Deliyannides D; Prasad KM; Huey ED
    BMJ Open; 2020 Feb; 10(2):e032112. PubMed ID: 32034019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.
    Devanand DP
    Curr Neurol Neurosci Rep; 2018 Jul; 18(9):55. PubMed ID: 30008124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
    Wozniak MA; Frost AL; Itzhaki RF
    Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
    Powell-Doherty RD; Abbott ARN; Nelson LA; Bertke AS
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.
    Breier A; Buchanan RW; D'Souza D; Nuechterlein K; Marder S; Dunn W; Preskorn S; Macaluso M; Wurfel B; Maguire G; Kakar R; Highum D; Hoffmeyer D; Coskinas E; Litman R; Vohs JL; Radnovich A; Francis MM; Metzler E; Visco A; Mehdiyoun N; Yang Z; Zhang Y; Yolken RH; Dickerson FB
    Schizophr Res; 2019 Apr; 206():291-299. PubMed ID: 30478008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.
    Prasad KM; Eack SM; Keshavan MS; Yolken RH; Iyengar S; Nimgaonkar VL
    Schizophr Bull; 2013 Jul; 39(4):857-66. PubMed ID: 22446565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1.
    Wozniak MA; Frost AL; Preston CM; Itzhaki RF
    PLoS One; 2011; 6(10):e25152. PubMed ID: 22003387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights of Valacyclovir in Treatment of Alzheimer's Disease: Computational Docking Studies and Scopolamine Rat Model.
    Patel P; Faldu K; Borisa A; Bhatt H; Shah J
    Curr Neurovasc Res; 2022; 19(3):344-357. PubMed ID: 36089794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE).
    Salloway S; Honigberg LA; Cho W; Ward M; Friesenhahn M; Brunstein F; Quartino A; Clayton D; Mortensen D; Bittner T; Ho C; Rabe C; Schauer SP; Wildsmith KR; Fuji RN; Suliman S; Reiman EM; Chen K; Paul R
    Alzheimers Res Ther; 2018 Sep; 10(1):96. PubMed ID: 30231896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paper.
    Goldhardt O; Freiberger R; Dreyer T; Willner L; Yakushev I; Ortner M; Förstl H; Diehl-Schmid J; Milz E; Priller J; Ramirez A; Magdolen V; Thaler M; Grimmer T
    Alzheimers Dement; 2023 May; 19(5):2117-2134. PubMed ID: 36396609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
    Aurelius E; Franzen-Röhl E; Glimåker M; Akre O; Grillner L; Jorup-Rönström C; Studahl M;
    Clin Infect Dis; 2012 May; 54(9):1304-13. PubMed ID: 22460966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
    Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
    J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
    Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
    JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emotion discrimination in humans: Its association with HSV-1 infection and its improvement with antiviral treatment.
    Bhatia T; Wood J; Iyengar S; Narayanan SS; Beniwal RP; Prasad KM; Chen K; Yolken RH; Dickerson F; Gur RC; Gur RE; Deshpande SN; Nimgaonkar VL
    Schizophr Res; 2018 Mar; 193():161-167. PubMed ID: 28830742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.